Advertisement
Canada markets closed

  • S&P/TSX

    21,728.55
    +14.01 (+0.06%)
     

  • S&P 500

    5,018.39
    -17.30 (-0.34%)
     

  • DOW

    37,903.29
    +87.37 (+0.23%)
     

  • CAD/USD

    0.7284
    +0.0023 (+0.31%)
     

  • CRUDE OIL

    79.13
    +0.13 (+0.16%)
     

  • Bitcoin CAD

    79,243.79
    -3,353.12 (-4.06%)
     

  • CMC Crypto 200

    1,202.07
    -136.99 (-10.23%)
     

  • GOLD FUTURES

    2,330.20
    +27.30 (+1.19%)
     

  • RUSSELL 2000

    1,980.23
    +6.32 (+0.32%)
     

  • 10-Yr Bond

    4.5950
    -0.0910 (-1.94%)
     

  • NASDAQ futures

    17,474.75
    -96.50 (-0.55%)
     

  • VOLATILITY

    15.39
    -0.26 (-1.66%)
     

  • FTSE

    8,121.24
    -22.89 (-0.28%)
     

  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     

  • CAD/EUR

    0.6795
    -0.0007 (-0.10%)
     

S&P 500 struggles for direction as regional banks rebound, but health care weighs

Investing.com
·2 min read

Investing.com -- The S&P 500 slipped between gains and losses Tuesday as investors digested a slip in health care stocks and renewed investor appetite for regional banking stocks.

The S&P 500 was up 0.2%, the Dow Jones Industrial Average fell 0.1%, or 36 points lower, and the Nasdaq gained 0.4%.

Financials were the top performing sector on the day, led by regional banks including U.S. Bancorp (NYSE:USB), Zions Bancorporation (NASDAQ:ZION) and East West Bancorp (NASDAQ:EWBC) as investors appear keen to buy into the weakness seen in the spring.

Microsoft Corporation (NASDAQ:MSFT) and Alphabet (NASDAQ:GOOGL), meanwhile, helped push tech stocks higher though Apple (NASDAQ:AAPL) continued to trade in the red after unveiling its Vision Pro headsets on Monday.

ADVERTISEMENT

The higher-than-expected price of $3,499 for the headset could limit adoption and any meaningful boost to revenue in the near term, according to UBS

“[W]ith a starting price of $3,499, roughly $500 above our expectations and an availability date in early 2024, we estimate the impact over the next 12-18 months will likely be no more than 1%-2% of total revenue,” UBS added.

Health stocks were pressured by a slump in Elevance Health Inc (NYSE:ELV), Merck (NYSE:MRK) and Illumina Inc (NASDAQ:ILMN), with the latter down more than 4% as it continues its fight with regulators to save the deal to acquire cancer startup Grail.

Illumina Inc (NASDAQ:ILMN) on Monday appealed against a Federal Trade Commission order that demanded the company to unwind its $7 billion acquisition of Grail.

Boeing (NYSE:BA), a major dow component, was also big drag on the market falling 2% after the aircraft maker said it would delay deliveries of its 737 Dreamliner jets, citing a production flaw.

In crypto-related news, the regulatory heat turned up a notch as the SEC filed a lawsuit against Coinbase Global (NASDAQ:COIN) accusing the cryptocurrency platform of breaking U.S. regulations, sending its shares more than 12% lower.

The move comes just a day after the SEC sued Binance, alleging multiple security violations including misappropriating customer funds.

Cryptocurrencies, however, sidestepped the regulatory worries as Bitcoin (BitfinexUSD), ETH/USD and XRP led the broader crypto move higher.

Related Articles

EV maker Fisker pushes into emission credit market to boost sagging business

US SEC sues crypto exchange Coinbase, one day after suing Binance